08/11/2025
4:25 PM | Capricor Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/29/2025
10:23 AM | Capricor Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
| Form SCHEDULE 13G | |
07/11/2025
5:35 AM | Capricor Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/27/2025
8:15 AM | Capricor Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/09/2025
4:15 PM | Capricor Therapeutics (Filer)
| Form ARS | |
04/08/2025
4:15 PM | Capricor Therapeutics (Filer)
| Form DEF 14A | |
03/19/2025
3:13 PM | Capricor Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/04/2025
6:00 PM | Capricor Therapeutics (Issuer)
DUNBAR GEORGE W JR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
6:00 PM | Capricor Therapeutics (Issuer)
Litvack Frank (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
6:00 PM | Bergmann Anthony (Reporting)
Capricor Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
6:05 AM | Capricor Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Get the Latest News and Ratings for CAPR and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Capricor Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
02/28/2025
6:30 PM | Capricor Therapeutics (Issuer)
COLLIER EARL M JR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/30/2025
8:34 PM | Capricor Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
| Form SCHEDULE 13G | |
01/06/2025
6:32 PM | Capricor Therapeutics (Issuer)
Litvack Frank (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/06/2025
6:00 PM | Capricor Therapeutics (Issuer)
Gotwals Philip J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/06/2025
6:00 PM | Capricor Therapeutics (Issuer)
COLLIER EARL M JR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/06/2025
6:00 PM | Capricor Therapeutics (Issuer)
DUNBAR GEORGE W JR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/06/2025
6:00 PM | Capricor Therapeutics (Issuer)
Musket David B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/06/2025
6:00 PM | Capricor Therapeutics (Issuer)
Sabar Karimah Es (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/06/2025
6:00 PM | Auwaerter Paul Gisbert (Reporting)
Capricor Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/06/2025
6:00 PM | Capricor Therapeutics (Issuer)
Kelliher Mike (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/06/2025
6:00 PM | Capricor Therapeutics (Issuer)
Marban Linda (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/06/2025
6:00 PM | Capricor Therapeutics (Issuer)
Krasney Karen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/06/2025
6:00 PM | Bergmann Anthony (Reporting)
Capricor Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/02/2025
1:17 PM | Capricor Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/16/2024
8:25 AM | Capricor Therapeutics (Issuer)
Krasney Karen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/13/2024
3:02 PM | Capricor Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/12/2024
10:46 AM | BlackRock, Inc. (Filed by)
Capricor Therapeutics (Subject)
| Form SC 13G | |
11/08/2024
8:00 AM | Capricor Therapeutics (Subject)
HIGHBRIDGE CAPITAL MANAGEMENT LLC (Filed by)
| Form SC 13G/A | |
10/24/2024
1:02 PM | BlackRock, Inc. (Filed by)
Capricor Therapeutics (Subject)
| Form SC 13G | |
10/22/2024
4:11 PM | Capricor Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
10/17/2024
3:15 PM | Capricor Therapeutics (Filer)
| Form 424B5 | |
10/16/2024
11:15 PM | Capricor Therapeutics (Filer)
| Form EFFECT | |
10/17/2024
5:01 AM | Capricor Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/16/2024
3:25 PM | Capricor Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/16/2024
3:35 PM | Capricor Therapeutics (Filer)
| Form 424B5 | |
10/16/2024
12:31 PM | Capricor Therapeutics (Filer)
| Form S-3/A | |
10/09/2024
8:16 AM | Capricor Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/24/2024
3:03 PM | Capricor Therapeutics (Subject)
Nippon Shinyaku Co Ltd (Filed by)
| Form SC 13G/A | |
09/24/2024
3:01 PM | Capricor Therapeutics (Issuer)
Nippon Shinyaku Co Ltd (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/24/2024
3:01 PM | Capricor Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Why More Investors Are Using Family Trusts to Protect Their Wealth (Ad) For many investors, a family trust can be an essential tool for protecting assets, avoiding probate, and ensuring wealth is passed on according to your wishes. Trusts may also provide shielding from creditors and lawsuits while offering potential tax advantages—especially with estate tax thresholds set to decrease in 2026.
If you’re considering whether a family trust is right for you, speaking with a fiduciary financial advisor can help you decide the best path forward. We’ve created a free tool that matches you with vetted advisors in your area—each legally bound to act in your best interest. Click here to get your free advisor matches and start planning your legacy today. |
09/17/2024
8:15 AM | Capricor Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
MarketBeat All Access